In Real Life, Low-Level HER2 Expression May Be Associated With Better Outcome in HER2-Negative Breast Cancer: A Study of the National Cancer Center, ChinaYiqun Li, Binghe Xu, Nilupai Abudureheiyimu et al.|Frontiers in Oncology|2022Cited by 119
Incidence, risk factors and survival of patients with brain metastases at initial metastatic breast cancer diagnosis in ChinaYiqun Li, Binghe Xu, Shaoyan Lin et al.|The Breast|2020Cited by 21
Clinicopathological characteristics and survival outcomes in patients with synchronous lung metastases upon initial metastatic breast cancer diagnosis in Han populationShaoyan Lin, Binghe Xu, Hongnan Mo et al.|BMC Cancer|2021Cited by 12
Real world initial palliative treatment patterns and clinical outcomes in premenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer: A study of the National Cancer Center, ChinaYiqun Li, Binghe Xu, Hongnan Mo et al.|The Breast|2021Cited by 10
Risk Factors and Survival of Patients With Liver Metastases at Initial Metastatic Breast Cancer Diagnosis in Han PopulationShaoyan Lin, Binghe Xu, Hongnan Mo et al.|Frontiers in Oncology|2021Cited by 7